For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220822:nRSV7695Wa&default-theme=true
RNS Number : 7695W Star Phoenix Group Ltd 22 August 2022
22 August 2022
Star Phoenix Group Ltd
("Star Phoenix" or the "Company")
UPDATE ON ARBITRATION PROCEEDINGS AGAINST LANDOCEAN
- STAGE 1 CLAIMS AWARDED
Star Phoenix (AIM: STA), an international company with an oilfield services
business in Trinidad and an oil and gas interest in Indonesia, is pleased to
update that, further to the Company's announcement on 27 May 2022, the London
Court of International Arbitration ("LCIA") issued a consent award on 12
August 2022 (of which the Company was notified on 19 August 2022) in relation
to two of the four Stage 1 Claims. Under the consent award, LandOcean is
required to make payment of US$301,265 to Star Phoenix by 16 September 2022,
being 35 days from the date of the consent award.
The issuing of the consent award makes a successful conclusion of two of the
four Stage 1 Claims. The Company will provide further updates on the remaining
Stage 1 Claims in due course.
This announcement has been approved by Chairman Lubing Liu on behalf of the
Company.
Contact Details
WH Ireland Limited (Nominated Adviser and Broker)
Star Phoenix Group Ltd James Joyce / Ben Good
Robin Luo (Company Secretary) t. +44 (0)20 7220 1666
e. admin@starphoenixgroup.com (mailto:admin@starphoenixgroup.com)
t. +61 8 6205 3012
This announcement contains inside information for the purposes of Article 7 of
the UK version of Regulation (EU) No 596/2014 which is part of UK law by
virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon
the publication of this announcement via a Regulatory Information Service,
this inside information is now considered to be in the public domain.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUURKRUAUWURR